Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
Public ClinicalTrials.gov record NCT05902169. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Open-label, Multicentric, Two-arm Pivotal Trial of SonoCloud-9 Combined With Carboplatin (CBDCA) vs Standard of Care Lomustine (CCNU) or Temozolomide (TMZ) in Patients Undergoing Planned Resection for First Recurrence Glioblastoma.
Study identification
- NCT ID
- NCT05902169
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- CarThera
- Industry
- Enrollment
- 560 participants
Conditions and interventions
Conditions
Interventions
- Carboplatin Drug
- Lomustine Drug
- SonoCloud-9 (SC9) Device
- Temozolomide Drug
Drug · Device
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 28, 2024
- Primary completion
- Jan 27, 2028
- Completion
- Jun 29, 2028
- Last update posted
- Apr 23, 2026
2024 – 2028
United States locations
- U.S. sites
- 19
- U.S. states
- 14
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic Arizona | Phoenix | Arizona | 805054 | Active, not recruiting |
| University of California, San Francisco | San Francisco | California | 94143 | Active, not recruiting |
| UCHealth | Aurora | Colorado | 80011 | Active, not recruiting |
| Mayo Clinic of Jacksonville Florida | Jacksonville | Florida | 32224 | Active, not recruiting |
| Miami Cancer Institute | Miami | Florida | 33176 | Active, not recruiting |
| Moffitt Cancer Center | Tampa | Florida | 33612 | Active, not recruiting |
| Winship Cancer Institute at Emory University | Atlanta | Georgia | 30322 | Active, not recruiting |
| Northwestern University | Chicago | Illinois | 60611 | Active, not recruiting |
| Indiana University Health | Indianapolis | Indiana | 46202 | Active, not recruiting |
| John Hopkins University | Baltimore | Maryland | 21287 | Active, not recruiting |
| Mayo Clinic Rochester | Rochester | Minnesota | 55905 | Active, not recruiting |
| Weill Cornell Medicine | New York | New York | 10021 | Active, not recruiting |
| NewYork-Presbyterian / Columbia University Irving Medical Center | New York | New York | 10032 | Active, not recruiting |
| Lennox Hill Hospital | New York | New York | 10075 | Active, not recruiting |
| University of North Carolina | Chapel Hill | North Carolina | 27516 | Active, not recruiting |
| Penn State Health Milton S. Hershey Medical Center | Hershey | Pennsylvania | 17033 | Active, not recruiting |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390 | Active, not recruiting |
| University of Texas Houston Health Science Center | Houston | Texas | 77030 | Active, not recruiting |
| University of Utah, Hunstman Cancer Institute | Salt Lake City | Utah | 84112 | Active, not recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 29 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05902169, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 23, 2026 · Synced Apr 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05902169 live on ClinicalTrials.gov.